益舒心錠10公絲 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

益舒心錠10公絲

宗誠貿易有限公司 台北巿民權西路36號2F (30430674) - isosorbide dinitrate (trituration with lactose) - 錠劑 - isosorbide dinitrate (trituration with lactose) (2412208402) (25%) 40mg - 預防狹心症之發作

益舒心錠5公絲 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

益舒心錠5公絲

宗誠貿易有限公司 台北巿民權西路36號2F (30430674) - isosorbide dinitrate (trituration with lactose) - 錠劑 - isosorbide dinitrate (trituration with lactose) (2412208402) (25%) 20mg - 預防狹心症之發作

益舒心舌下錠2.5公絲 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

益舒心舌下錠2.5公絲

宗誠貿易有限公司 台北巿民權西路36號2F (30430674) - isosorbide dinitrate (trituration with lactose) - 舌下錠 - isosorbide dinitrate (trituration with lactose) (2412208402) (25%) 10mg - 治療及預防狹心症之發作

富利心舌下錠 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

富利心舌下錠

廣福西藥行 台北巿德行東路129巷12號 - isosorbide dinitrate (trituration with lactose) - 舌下錠 - isosorbide dinitrate (trituration with lactose) (2412208402) (12.5mg) 5mg - 預防狹心症之發作

幫賜諾錠 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

幫賜諾錠

臺灣東洋藥品工業股份有限公司 台北市南港區園區街3之1號3樓 (11821341) - porcine pancreatin with lipase 2000 ph.eur.unit total proteases 150 ph.eur.unit amylase 2500 ph.eur.unit;;ox bile extract;;pyloric extract with intrinsic factor activity (eq to pyloric extract with intrinsic factor concentrate 3.75mg);;porcine gastric extract (pepsin eq to proteolytic activity 13 ph. eur.units ...20mg) - 糖衣錠 - pyloric extract with intrinsic factor activity (eq to pyloric extract with intrinsic factor concentrate 3.75mg) (2008003230) mg; ox bile extract (5616000316) mg; porcine pancreatin with lipase 2000 ph.eur.unit total proteases 150 ph.eur.unit amylase 2500 ph.eur.unit (5616006300) 42.859-29.273mg; porcine gastric extract (pepsin eq to proteolytic activity 13 ph. eur.units ...20mg) (5616006520) mg - multienzymes (lipase, protease etc.) - 胃腸道之消化酵素缺乏症。

樂利膠囊 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

樂利膠囊

三合興化學製藥廠有限公司 台北巿貴德街47號之5 - liver hydrolysate with essential amino acid;;cysteine;;choline bitartrate;;inositol (meso-inositol);;vitamin b - 膠囊劑 - liver hydrolysate with essential amino acid (2004800401) 70mg; cysteine (4020100500) 20mg; choline bitartrate (5624000400) 100mg; vitamin b (8810000500) 1.5mcg; inositol (meso-inositol) (8813000100) 25mg - 營養補給

庫魯泛斯錠 500毫克/2.5毫克 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

庫魯泛斯錠 500毫克/2.5毫克

嘉德藥品企業股份有限公司 台北市中山區民生東路二段176號5樓 (04706351) - metformin hydrochloride with 0.5% magnesium stearate;;glyburide (eq to glibenclamide) - 膜衣錠 - metformin hydrochloride with 0.5% magnesium stearate (6820400720) mg; glyburide (eq to glibenclamide) (6820600700) mg - metformin and sulfonylureas - 第二型糖尿病。

庫魯泛斯錠 500毫克/5毫克 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

庫魯泛斯錠 500毫克/5毫克

嘉德藥品企業股份有限公司 台北市中山區民生東路二段176號5樓 (04706351) - metformin hydrochloride with 0.5% magnesium stearate;;glyburide (eq to glibenclamide) - 膜衣錠 - metformin hydrochloride with 0.5% magnesium stearate (6820400720) mg; glyburide (eq to glibenclamide) (6820600700) mg - metformin and sulfonylureas - 第二型糖尿病。

尼菲士持續性藥效錠30毫克 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

尼菲士持續性藥效錠30毫克

瑩碩生技醫藥股份有限公司 台北市中山區南京東路二段206號8樓之3 (80207616) - nifedipine (within 24hours nifedipine released by 30mg ) - 持續性藥效錠 - nifedipine (within 24hours nifedipine released by 30mg ) (2412400930) mg - nifedipine - 狹心症、高血壓。

"霖揚"阿扎賽德苷凍晶注射劑100毫克 Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"霖揚"阿扎賽德苷凍晶注射劑100毫克

霖揚生技製藥股份有限公司 苗栗縣竹南鎮頂埔里科研路50-3號4樓、50-5號4樓、50-8號3樓、50-8號4樓、50-8號5樓、50-9號5樓 (24890496) - azacitidine - 凍晶注射劑 - azacitidine (1008400500) mg - azacitidine - 治療骨髓增生不良症候群高危險性的病患high risk mds:頑固性貧血併有過量芽細胞(ra with excess blasts,raeb)、轉變中的頑固性貧血併有過量芽細胞(raeb in transformation,raeb-t)、及慢性骨髓單核細胞性白血病(chronic myelomonocytic leukemia, cmmol)。azacitidine適用於治療65歲(含)以上,不適合接受hsct或密集化學治療、且骨髓芽細胞比例>30%的aml成人患者(依據who分類)。